{"id":62879,"date":"2021-05-11T07:16:07","date_gmt":"2021-05-11T05:16:07","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/"},"modified":"2025-10-13T15:32:34","modified_gmt":"2025-10-13T13:32:34","slug":"genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/","title":{"rendered":"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n"},"content":{"rendered":"<p><strong>Gracias al apoyo de <a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/genesis-biomed\/\" target=\"_blank\" rel=\"noopener\">Genesis Biomed<\/a>, Telara Pharma -una<em> spin-off<\/em> del <a href=\"https:\/\/www.comunidad.madrid\/hospital\/gregoriomaranon\/\" target=\"_blank\" rel=\"noopener\">Hospital Gregorio Mara\u00f1\u00f3n<\/a>\u2013 ha subscrito un acuerdo de licencia exclusiva mundial con la biotecnol\u00f3gica canadiense <a href=\"https:\/\/archbiopartners.com\/\" target=\"_blank\" rel=\"noopener\">Arch Biopartners<\/a> para el uso de la cilastatina como tratamiento y prevenci\u00f3n de la lesi\u00f3n renal aguda y procesos de sepsis. La consultora -con sede en el Parc Cient\u00edfic de Barcelona y especializada en proyectos de I+D+i en biomedicina- tambi\u00e9n contribuy\u00f3 a la creaci\u00f3n de la compa\u00f1\u00eda, apoyando en la gesti\u00f3n estrat\u00e9gica del proyecto y liderando el cierre de una ronda semilla de 100.000 \u20ac.<\/strong><\/p>\n<p>La cilastatina es una mol\u00e9cula peque\u00f1a inhibidora de la enzima dipeptidasa-1 (DPEP-1) desarrollada en la d\u00e9cada de 1980 para prevenir la degradaci\u00f3n del antibi\u00f3tico imipenem en el ri\u00f1\u00f3n. Hasta ahora, el uso de la cilastatina se limita a la combinaci\u00f3n en formulaci\u00f3n dual con este f\u00e1rmaco y todav\u00eda no se ha aprobado como producto independiente.<\/p>\n<p>Despu\u00e9s de un largo proceso de investigaci\u00f3n iniciado en la d\u00e9cada de 1980, investigadores del <a href=\"https:\/\/www.comunidad.madrid\/hospital\/gregoriomaranon\/profesionales\/relacion-especialidades\/nefrologia\" target=\"_blank\" rel=\"noopener\">Servicio de Nefrolog\u00eda<\/a> del Hospital General Universitario Gregorio Mara\u00f1\u00f3n, liderados por el jefe del servicio, el \u00a0demostraron que la cilastatina protege el ri\u00f1\u00f3n en m\u00e1s de un 80 por ciento frente a la toxicidad de f\u00e1rmacos tan ampliamente utilizados como el cisplatino, la ciclosporina o la gentamicina, f\u00e1rmacos esenciales en el tratamiento de ciertos c\u00e1nceres, trasplantes o infecciones. Estos tratamientos, cuando provocan toxicidad renal, deben cambiarse por alternativas terap\u00e9uticas menos eficaces, m\u00e1s costosas para la sanidad p\u00fablica y con mayores complicaciones para el paciente, e incluso en ocasiones obliga a interrumpir el tratamiento con el riesgo que ello supone. Recientemente el <a href=\"https:\/\/www.comunidad.madrid\/hospital\/gregoriomaranon\/noticia\/hospital-gregorio-maranon-despide-doctor-alberto-tejedor-fallecido-covid\" target=\"_blank\" rel=\"noopener\">Dr. Tejedor falleci\u00f3 a causa de la COVID-19<\/a> y el liderazgo cient\u00edfico del proyecto lo asumi\u00f3 el <strong>Dr. Alberto L\u00e1zaro.<\/strong><\/p>\n<div id=\"attachment_62854\" style=\"width: 606px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-62854\" class=\"wp-image-62854 \" src=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/alberto_tejedor-1.jpg\" alt=\"\" width=\"596\" height=\"323\" srcset=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/alberto_tejedor-1.jpg 900w, https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/alberto_tejedor-1-300x163.jpg 300w, https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/alberto_tejedor-1-768x416.jpg 768w\" sizes=\"auto, (max-width: 596px) 100vw, 596px\" \/><p id=\"caption-attachment-62854\" class=\"wp-caption-text\">Dr. Alberto Tejedor (Foto: Hospital Gregorio Mara\u00f1\u00f3n).<\/p><\/div>\n<p>El Hospital Gregorio Mara\u00f1\u00f3n patent\u00f3 la capacidad del compuesto cilastatina para prevenir y tratar el fracaso renal agudo y, a trav\u00e9s de su Instituto de Investigaci\u00f3n Sanitaria \u00a0(<a href=\"https:\/\/www.iisgm.com\/\" target=\"_blank\" rel=\"noopener\">IiSGM<\/a>), ya ha realizado todos los ensayos precl\u00ednicos pertinentes y ha publicado los estudios en revistas cient\u00edficas internacionales que avalan los resultados.<\/p>\n<p>El nuevo f\u00e1rmaco -el primer nefroprotector mundial de estas caracter\u00edsticas- abre la posibilidad de mejorar y ampliar los tratamientos m\u00e1s eficaces, actualmente conocidos, para enfermedades como el c\u00e1ncer, el VIH e inmunosupresores para evitar el rechazo en los trasplantes, y el uso de antibi\u00f3ticos para el tratamiento de infecciones que no se pod\u00edan utilizar por su alta toxicidad renal. Adem\u00e1s, est\u00e1 demostrado que la preservaci\u00f3n renal contribuye a disminuir significativamente la tasa de mortalidad en pacientes s\u00e9pticos.<\/p>\n<p>Arch Biopartners dispone de una mol\u00e9cula, <a href=\"https:\/\/archbiopartners.com\/index.php\/our-science\/our-key-platforms\/metablok\" target=\"_blank\" rel=\"noopener\">metablok<\/a>, con el mismo mecanismo de acci\u00f3n. Ahora, el Hospital Gregorio\u00a0Mara\u00f1\u00f3n\u00a0cede de manera exclusiva a la biotecnol\u00f3gica canadiense los derechos comerciales de las patentes sobre el uso de la\u00a0cilastatina\u00a0para tratar la lesi\u00f3n renal aguda y sepsis. Este acuerdo de licencia abre la puerta para un nuevo ensayo de fase II para\u00a0metablok\u00a0y\u00a0cilastatina, que allane el camino a a la mejor selecci\u00f3n de terapias para los inhibidores de\u00a0DPEP-1\u00a0y a una llegada m\u00e1s r\u00e1pida de estas mol\u00e9culas al mercado.<\/p>\n<p>Genesis Biomed apoyar\u00e1 a Telara Pharma en la gesti\u00f3n estrat\u00e9gica de la compa\u00f1\u00eda y en la promoci\u00f3n del proyecto cilastatina. Por otro lado, Telara y el Hospital Gregorio Mara\u00f1\u00f3n participar\u00e1n del desarrollo cl\u00ednico de la cilastatina, dirigido por Arch Biopartners.<\/p>\n<div id=\"attachment_62812\" style=\"width: 610px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-62812\" class=\"wp-image-62812 size-full\" src=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/jordi-ortiz-1.jpg\" alt=\"\" width=\"600\" height=\"391\" srcset=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/jordi-ortiz-1.jpg 600w, https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/jordi-ortiz-1-300x196.jpg 300w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><p id=\"caption-attachment-62812\" class=\"wp-caption-text\">Jordi Ortiz (Foto: Genesis Biomed).<\/p><\/div>\n<p>Seg\u00fan<strong> Jordi Ortiz<\/strong>, CEO interino de Telara Pharma y consultor senior de Genesis Biomed, \u201ceste acuerdo de licencia permitir\u00e1 reducir el <em>time to market<\/em> y conseguir que cilastatina sea administrada a los pacientes muy pronto. Adem\u00e1s, conseguiremos cumplir el sue\u00f1o del Dr. Tejedor\u201d.<\/p>\n<p>Por su parte, el <strong>Dr. Alberto L\u00e1zaro<\/strong>, cofundador de Telara, afirma que: \u201ctodos los a\u00f1os de trabajo investigador habr\u00e1n merecido la pena si una \u00fanica persona pudiera beneficiarse de los efectos nefroprotectores de cilastatina. Cada vez estamos m\u00e1s cerca de la realizaci\u00f3n de un ensayo fase II que demuestre la eficacia cl\u00ednica y de ah\u00ed la comercializaci\u00f3n para su uso en el paciente\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gracias al apoyo de Genesis Biomed, Telara Pharma -una spin-off del Hospital Gregorio Mara\u00f1\u00f3n\u2013 ha subscrito un acuerdo de licencia exclusiva mundial con la biotecnol\u00f3gica canadiense Arch Biopartners para el&#8230;<\/p>\n","protected":false},"author":14,"featured_media":62799,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-62879","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Gracias al apoyo de Genesis Biomed, Telara Pharma -una spin-off del Hospital Gregorio Mara\u00f1\u00f3n\u2013 ha subscrito un acuerdo de licencia exclusiva mundial con la biotecnol\u00f3gica canadiense Arch Biopartners para el...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-11T05:16:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:32:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Foto-Hospital-Gregorio-Maranon.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1650\" \/>\n\t<meta property=\"og:image:height\" content=\"1022\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n\",\"datePublished\":\"2021-05-11T05:16:07+00:00\",\"dateModified\":\"2025-10-13T13:32:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/\"},\"wordCount\":757,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Foto-Hospital-Gregorio-Maranon.jpg\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/\",\"name\":\"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Foto-Hospital-Gregorio-Maranon.jpg\",\"datePublished\":\"2021-05-11T05:16:07+00:00\",\"dateModified\":\"2025-10-13T13:32:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Foto-Hospital-Gregorio-Maranon.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Foto-Hospital-Gregorio-Maranon.jpg\",\"width\":1650,\"height\":1022},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/","og_locale":"es_ES","og_type":"article","og_title":"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n - Parc Cient\u00edfic de Barcelona","og_description":"Gracias al apoyo de Genesis Biomed, Telara Pharma -una spin-off del Hospital Gregorio Mara\u00f1\u00f3n\u2013 ha subscrito un acuerdo de licencia exclusiva mundial con la biotecnol\u00f3gica canadiense Arch Biopartners para el...","og_url":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2021-05-11T05:16:07+00:00","article_modified_time":"2025-10-13T13:32:34+00:00","og_image":[{"width":1650,"height":1022,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Foto-Hospital-Gregorio-Maranon.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n","datePublished":"2021-05-11T05:16:07+00:00","dateModified":"2025-10-13T13:32:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/"},"wordCount":757,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Foto-Hospital-Gregorio-Maranon.jpg","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/","url":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/","name":"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Foto-Hospital-Gregorio-Maranon.jpg","datePublished":"2021-05-11T05:16:07+00:00","dateModified":"2025-10-13T13:32:34+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Foto-Hospital-Gregorio-Maranon.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Foto-Hospital-Gregorio-Maranon.jpg","width":1650,"height":1022},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-biomed-impulsa-telara-pharma-una-spin-off-del-hospital-gregorio-maranon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Genesis Biomed impulsa Telara Pharma, una spin-off del Hospital Universitario Gregorio Mara\u00f1\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/62879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=62879"}],"version-history":[{"count":4,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/62879\/revisions"}],"predecessor-version":[{"id":62887,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/62879\/revisions\/62887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/62799"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=62879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=62879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=62879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}